Asia-Pacific Digital Pathology Market Size Expected to reach $0.39 billion by 2031

Asia-Pacific digital pathology market size was valued at $143.32 Million in 2021, and is projected to reach $393.33 Million by 2031, registering a CAGR of 10.6%." Digital pathology is a diagnosis technique carried out by the use of various computer technologies. Digitized specimen slide generates information that is managed by advanced computation and through virtual microscopy. Advances in medical science and computer technology have all contributed to the development of digital pathology.. It offers a high-resolution sample scanning, analysis of computer images, and online storage of digital slides which enables pathologists to examine slides without forensic evidence.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/30630

Digital pathology scanners can scan slides in as little as 30 seconds, be configured at multiple magnifications, and handle up to 1,000 slides at a time. Storage, now available in the cloud, is affordable, secure, and accessible. Computational applications incorporating artificial intelligence (AI) offer a myriad of ways to analyze and present images to the pathologist.

Digital pathology is rapidly gaining momentum as a proven and essential technology, with specific support for education, tissue-based research, drug development, and the practice of human pathology throughout the world. It is an innovation committed to the reduction of laboratory expenses, an improvement of operational efficiency, enhanced productivity, and improving treatment decisions and patient care. Some of the advantages associated with digital pathology are easy access of digital images and video streams which can be shared in real-time, thus bridging physical distance (telepathology) between local hospitals, colleges (second-opinion), teachers and students, and between home and workplace (home-office).

Digital pathology is used primarily in three ways. First, to efficiently design research protocol, collect data, and manage databases for the millions of specimens. Second, clinical labs use digital pathology on select cases for remote consultations, education, or quantitative analysis. And third and fastest-growing use case centers on clinical labs moving to an all-digital workflow. These labs use computationally-enabled digital pathology powered by AI to help assign cases to pathologists, manage the workflow into worklists, offer quantitative image analysis for specific case types, integrate information into the existing Lab Information System (LIS).

𝐁𝐮𝐲 𝐍𝐨𝐰 https://www.alliedmarketresearch.com/checkout-final/84c39672bc4411dbbde489a2cc11b395

By end user the market is segmented into educational, clinical and pharma & biotech companies. In 2021, the pharma & biotech companies exhibited the highest growth, and is anticipated to lead during the forecast period, owing to the collaboration among various pharma & biotech companies which further helps in the development of advanced diagnostics devices.

The clinical segment is anticipated to be the fastest growing segment during the forecast period. Owing to increase in demand of clinical trial training applications which can be reformatted to drive quality improvement in routine practice, hence, contributing in the growth of Asia-Pacific digital pathology market

By country, Japan accounted for a majority of the digital pathology market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to increase in key players for the digital diagnosis software development which is one of the major factors for the growth of the market. India is anticipated to witness fastest growth, owing to rise in geriatric population and surge in use of digital pathology in drug development, data sharing with the payers, and high use of digital pathology for cancer cases.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/30630

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
By type, the scanners segment was the highest contributor to the market in 2021.

By application, the disease diagnosis was the highest contributor to the Asia-Pacific digital pathology market in 2021.

By end user, the clinical segment is projected to grow at a significant CAGR of 11.0% from 2022 to 2031.

By country, Japan garnered largest revenue share in 2021, whereas India is anticipated to grow at the highest CAGR of 14.4% during the review period.

𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.